34 results on '"Sharma, S."'
Search Results
2. A Ph-Ib study of TRK-950 combined with anti-cancer treatment regimens in patients with advanced solid tumors
3. Correlation of ultrasound elastography of breast lesions with histopathology and immunohistochemistry: Looking for prognostic significance
4. Role of Ultrasound Elastography in characterization of breast lesions: Does it really count?
5. Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer
6. Change in trend in various clinico-pathological factors and treatment profile of breast cancer patients in developing countries: A tertiary cancer center experience
7. 355 (PB135) - Cellular transporters as novel metabolic immune checkpoints: NGY-091, a small molecule dual MCT1/4 inhibitor for immuno oncology
8. 91 (PB081) - A Ph-Ib study of TRK-950 combined with anti-cancer treatment regimens in patients with advanced solid tumors
9. Change in trend in various clinic o-pathological factors and treatment profile of breast cancer patients in developing countries: A tertiary cancer center experience
10. Improving quality of sexual life among breast cancer survivors in developing countries: Living beyond breast cancer!
11. Can gene profiling be replaced by surrogate immunohistochemical panels for identification of molecular subtypes of breast cancer?
12. Post-mastectomy hypofractionated radiotherapy in stage II and III breast cancer
13. First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation
14. The role of High-Mobility Group Box 1 protein in mesenchymal–epithelial signalling in the tumour microenvironment
15. 488 (PB-121) - Can gene profiling be replaced by surrogate immunohistochemical panels for identification of molecular subtypes of breast cancer?
16. 339 (PB-134) - Change in trend in various clinic o-pathological factors and treatment profile of breast cancer patients in developing countries: A tertiary cancer center experience
17. 232 (PB-027) - Post-mastectomy hypofractionated radiotherapy in stage II and III breast cancer
18. 154 (PB-055) - Improving quality of sexual life among breast cancer survivors in developing countries: Living beyond breast cancer!
19. 11LBA Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
20. 572 Oral panobinostat in patients with advanced tumors and impaired renal function: Relationship between pharmacokinetics and key safety parameters
21. 105A - First-in-human study of BLU-554, a potent, highly-selective FGFR4 inhibitor designed for hepatocellular carcinoma (HCC) with FGFR4 pathway activation
22. 557 PRMT5, a Novel Epigenetic Target in Lung Cancers
23. AOS3 Control of urinary, rectal, and sexual symptoms after 3-D conformal radiotherapy for bladder cancer
24. 403 Cosmetic Results of High Dose Rate Brachytherapy Boost Versus Electron Beam Boost in the Treatment of Early Breast Cancer
25. 465 Role of Simultaneous Integrated Boost IMRT in Carcinoma Breast
26. SP 110 Epigenetics and drug resistance
27. 6055 POSTER Dosimetric Comparison of Three Dimensional Conformal Radiotherapy With Intensity Modulated Radiotherapy & Bone Marrow Sparing Intensity Modulated Radiotherapy in Preoperative Radiation of Locally Advanced Carcinoma Rectum
28. 8579 POSTER Low Dose Weekly Paclitaxel Versus Cisplatin Concurrent With Radiation in Advanced Head and Neck Cancer
29. 2058 POSTER IMRT as Focal Therapy in Chemo-Reduced Group II Retinoblastoma
30. 556 Poster - Role of Ultrasound Elastography in characterization of breast lesions: Does it really count?
31. 555 Poster - Correlation of ultrasound elastography of breast lesions with histopathology and immunohistochemistry: Looking for prognostic significance.
32. 369 Poster - Change in trend in various clinico-pathological factors and treatment profile of breast cancer patients in developing countries: A tertiary cancer center experience.
33. 378 - The role of High-Mobility Group Box 1 protein in mesenchymal–epithelial signalling in the tumour microenvironment.
34. 231 Poster - Assessing the benefits and toxicities of platinum containing neoadjuvant chemotherapy in triple negative breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.